IRIS
VETRANO, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.514
AS - Asia 2.166
EU - Europa 713
SA - Sud America 545
AF - Africa 111
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.420
SG - Singapore 1.279
BR - Brasile 460
CN - Cina 392
VN - Vietnam 218
FI - Finlandia 158
IT - Italia 112
DE - Germania 97
IE - Irlanda 79
NG - Nigeria 69
FR - Francia 58
IN - India 58
HK - Hong Kong 57
CA - Canada 50
GB - Regno Unito 39
SE - Svezia 38
NL - Olanda 34
AR - Argentina 31
MX - Messico 24
BD - Bangladesh 22
EC - Ecuador 18
ID - Indonesia 17
RU - Federazione Russa 16
TR - Turchia 16
JP - Giappone 14
ZA - Sudafrica 14
BE - Belgio 13
IQ - Iraq 13
IL - Israele 11
ES - Italia 10
PL - Polonia 10
PH - Filippine 8
PK - Pakistan 8
PY - Paraguay 8
SA - Arabia Saudita 8
UA - Ucraina 8
MA - Marocco 7
CO - Colombia 6
EG - Egitto 6
VE - Venezuela 6
CL - Cile 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
LT - Lituania 5
UY - Uruguay 5
UZ - Uzbekistan 5
DK - Danimarca 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
MY - Malesia 4
RO - Romania 4
TN - Tunisia 4
AU - Australia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
NO - Norvegia 2
OM - Oman 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CM - Camerun 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.053
Salva come PNG Salva come JPEG
Città #
Singapore 634
Wilmington 429
Chandler 388
Ashburn 281
Dallas 209
The Dalles 205
San Jose 159
Helsinki 156
San Mateo 145
Shanghai 143
Ann Arbor 128
Beijing 120
Boardman 96
Ho Chi Minh City 83
Leawood 81
Dublin 79
Lawrence 77
Princeton 77
New York 72
Benin City 68
Hanoi 56
Hong Kong 53
Paris 52
Fairfield 39
Los Angeles 38
Santa Clara 38
Woodbridge 37
Milan 30
São Paulo 30
Toronto 30
Amsterdam 29
Seattle 24
Abbiategrasso 21
Columbus 20
Council Bluffs 19
London 16
Pune 16
Phoenix 15
Buffalo 14
Chicago 14
Frankfurt am Main 14
Naples 14
Rio de Janeiro 14
Brussels 13
Assago 12
Munich 12
Orem 12
Belo Horizonte 11
Curitiba 11
Da Nang 11
Mexico City 10
Norwalk 10
Warsaw 10
Brooklyn 9
Chennai 9
Porto Alegre 9
Boston 8
Brasília 8
Charlotte 8
Falkenstein 8
San Francisco 8
Houston 7
Johannesburg 7
San Diego 7
Tokyo 7
Atlanta 6
Campinas 6
Denver 6
Guayaquil 6
Kocaeli 6
Montreal 6
Mumbai 6
Quito 6
Baghdad 5
Bishkek 5
Duque de Caxias 5
Fortaleza 5
Haiphong 5
Hangzhou 5
Jakarta 5
Montevideo 5
Ottawa 5
Riyadh 5
Tashkent 5
Alexandria 4
Bandung 4
Ciudad del Este 4
Feira de Santana 4
Las Vegas 4
Manchester 4
Monmouth Junction 4
Ribeirão Preto 4
São José 4
Thái Bình 4
Volta Redonda 4
Amman 3
Asunción 3
Beirut 3
Betim 3
Blumenau 3
Totale 4.632
Salva come PNG Salva come JPEG
Nome #
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 160
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 151
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 131
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 131
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 118
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 115
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 115
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 111
Colitis-associated cancer: the dark side of inflammatory bowel disease 110
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 110
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 110
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 103
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 103
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 99
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 95
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression 94
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 93
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 93
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 92
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 92
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 91
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 90
Colitis, microbiota and colon cancer: an infernal triangle 90
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study 89
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease 88
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 86
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 86
OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling 86
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer 85
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease 85
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. 85
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? 83
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 82
Multiple pathogenic roles of microvasculature in inflammatory bowel disease : a Jack of all trades 82
Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis 82
Antiendomysial antibody detection in fecal supernatants: In vivo proof that small bowel mucosa is the site of antiendomysial antibody production 82
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 81
Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease 80
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications 79
RISK OF MICROBIAL TRANSLOCATION IN PATIENTS UNDERGOING PER-ORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA. PRELIMINARY RESULTS 79
Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'? 78
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 76
Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11 76
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition 75
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 75
The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease 75
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges 75
Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation 73
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. 73
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 72
Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus 72
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease 72
The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind 71
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE 71
Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients 70
Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 70
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts 70
Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions 69
Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: A multicentre study 69
Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6 69
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 69
Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies 68
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 67
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 66
GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity 65
Antiendomysial Antibody Detection in Biopsy Culture Allows Avoidance of Gluten Challenge in Celiac Children 63
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE(2) pathway links innate sensing to epithelial homeostasis 63
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases 62
TNF-stimulated gene-6 (TSG-6) is a key regulator in switching stemness and biological properties of mesenchymal stem cells 61
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer 61
Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 60
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer 59
The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm 59
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer 59
Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled trial 58
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms 56
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017 55
In vitro Anti-inflammatory and Protective Effects of ibidì® on Intestinal Epithelial Cells 55
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis 55
Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection 54
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 52
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel 52
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease 50
The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework 50
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial 49
Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer 49
Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? 49
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 48
Forty-Eight Hours of Biopsy Culture Improve the Sensitivity of the in Vitro Gliadin Challenge in the Diagnosis of Celiac Disease 45
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? 43
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine 41
Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors 39
Totale 7.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 0 0 90
2021/2022455 27 3 8 77 4 2 12 54 41 38 157 32
2022/20231.103 182 65 96 118 107 85 3 76 184 104 67 16
2023/2024732 57 72 125 72 34 111 32 22 12 19 53 123
2024/20251.226 27 16 7 54 27 139 93 136 159 268 141 159
2025/20262.829 433 210 270 286 122 112 681 156 171 182 114 92
Totale 7.150